112 related articles for article (PubMed ID: 4914973)
21. Immunoprophylactic effect of dysentery vaccination by live dysentery vaccine Vadizen (Sh. flexneri T32-Istrati) in children and adult collectivities in BT County.
Cîmpeanu S; Harasim T; Popovici S; Popa T; Meitert T; Pencu E; Ciudin L; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):305-12. PubMed ID: 6400304
[No Abstract] [Full Text] [Related]
22. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
23. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
24. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).
Meitert T; Pencu E; Ciudin L; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299
[No Abstract] [Full Text] [Related]
25. [Research on active immunity of man in bacillary dysentery. 3. Maintenance of the non-pathogenic character of the Shigella flexneri 2a TXXXII strain orally administered to volunteers].
Istrati G; Meitert T; Ciufeco C
Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):677-86. PubMed ID: 5877879
[No Abstract] [Full Text] [Related]
26. Studies on the genetic control of shigella sub-group B type specific antigens. I. Behaviour of Shigella flexneri type specific antigens in sexual recombination of Shigella x E. coli.
Timakov VD; Petrovskaya VG; Bondarenko VM
Ann Inst Pasteur (Paris); 1970 Jan; 118(1):3-9. PubMed ID: 4906593
[No Abstract] [Full Text] [Related]
27. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
Istrati M; Istrati G
Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
[No Abstract] [Full Text] [Related]
28. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000.
Putnam SD; Riddle MS; Wierzba TF; Pittner BT; Elyazeed RA; El-Gendy A; Rao MR; Clemens JD; Frenck RW
Clin Microbiol Infect; 2004 Sep; 10(9):804-10. PubMed ID: 15355411
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.
Nguyen TV; Le PV; Le CH; Weintraub A
Antimicrob Agents Chemother; 2005 Feb; 49(2):816-9. PubMed ID: 15673777
[TBL] [Abstract][Full Text] [Related]
31. Blocking bacterial enterotoxins.
Donnelly JJ; Rappuoli R
Nat Med; 2000 Mar; 6(3):257-8. PubMed ID: 10700222
[No Abstract] [Full Text] [Related]
32. [Annual distribution of serotypes of Salmonella, Shigella, and infantile enteropathogenic Escherichia coli in the Republic of Argentina, 1979-1981].
Eiguer T; Butta N
Rev Argent Microbiol; 1983; 15(1):19-24. PubMed ID: 6400758
[TBL] [Abstract][Full Text] [Related]
33. [Study on the streptomycin-dependent Shigella flexneri strain for oral vaccination against dysentery].
Mel D; Stanković N
Vojnosanit Pregl; 1965 Jan; 22(6):381-7. PubMed ID: 5848528
[No Abstract] [Full Text] [Related]
34. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
[TBL] [Abstract][Full Text] [Related]
35. [Molecular biology in the pathogenesis of Shigella sp. and enteroinvasive Escherichia coli].
Rico-Martínez MG
Rev Latinoam Microbiol; 1995; 37(4):367-85. PubMed ID: 8900572
[TBL] [Abstract][Full Text] [Related]
36. Antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in PH County.
Cuteanu I; Malamen G; Vlad A; Meitert T; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):313-21. PubMed ID: 6400305
[No Abstract] [Full Text] [Related]
37. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
[TBL] [Abstract][Full Text] [Related]
38. Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp.
Brandal LT; Lindstedt BA; Aas L; Stavnes TL; Lassen J; Kapperud G
J Microbiol Methods; 2007 Feb; 68(2):331-41. PubMed ID: 17079041
[TBL] [Abstract][Full Text] [Related]
39. An update on Shigella vaccines.
Ashkenazi S; Cohen D
Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
[TBL] [Abstract][Full Text] [Related]
40. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
